nav-left cat-right
cat-right

Immunocore and GlaxoSmithKline team to work on imm...

Immunocore’s list of collaborators is beginning to look like a Who’s Who in Big Pharma. Today the biotech–which is developing T cell immunotherapy technology originally spun out of Oxford–added a deal-hungry AstraZeneca ($AZN) and its biologics team at MedImmune as its latest partner, which will now join Genentech and GlaxoSmithKline in exploring whether the biotech has really found a powerful new...

Celgene, Lilly back $100M VC for biotech startups ...

Three big players in the life sciences industry–Celgene ($CELG), Eli Lilly ($LLY) and GE Ventures–are chipping in to help fund a $100 million venture fund that will be used to launch up to 20 new biotech companies in New York City, adding some fuel to a small but growing fire of R&D efforts in the Big Apple. The Bloomberg administration took the lead on this project, according to The Wall Street Journal,...

Merck Serono, Kadimastem collaborate on cell-based...

Kadimastem has developed technologies to differentiate stem cells into oligodendrocytes, which are brain cells that produce myelin, the insulation for the neural wiring. In multiple sclerosis (MS), oligodendrocytes are destroyed by the immune system. Kadimastem and Merck Serono have been leveraging cell-based drug screening technology to discover compounds that stimulate differentiation and myelination. Such compounds may...

Royal Society of Chemistry announces a new reposit...

The Royal Society of Chemistry announces a new subject-based repository that will make it easier for researchers to find and share relevant journal articles and data from a single point of access. David James, the Royal Society of Chemistry’s Executive Director of Strategic Innovation, said: “The Chemical Sciences Repository will offer free-to-access chemistry publications and integrated data in a single...

Trio of New York biomedical institutions join forc...

Memorial Sloan-Kettering Cancer Center, The Rockefeller University and Weill Cornell Medical College announced today that they have formed the pioneering Tri-Institutional Therapeutics Discovery Institute, Inc. (Tri-I TDI) and have partnered with Takeda Pharmaceutical Company, Ltd. This new, groundbreaking institute, designed to expedite early-stage drug discovery into innovative treatments and therapies for patients, was...

CAS and Thieme Publishing Group Collaborate

Columbus, Ohio (June 10, 2013) – Chemical Abstracts Service (CAS), the world’s authority for chemical information, and Thieme Publishing Group, a leading publisher of scientific and medical journals and books, have announced that hundreds of thousands of experimental procedures for chemical reactions from two prestigious Thieme organic chemistry journals will soon be available in SciFinder®, the choice for chemistry...
Page 4 of 31« First...23456...102030...Last »